Jens von Bahr
CEO and Co-Founder @ Dopamine
Jens von Bahr is a seed investor at Dopamine focused on Health Care and Biotechnology. Jens von Bahr is the CEO and Co-Founder at Evolution Gaming. Jens von Bahr attended Stockholm University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jens von Bahr invests in
Stages Jens von Bahr invests in
Countries Jens von Bahr invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Biotechnology 2 (50%)
- Art 1 (25%)
- Medical 1 (25%)
- Auctions 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Funding Round 1 (25%)
- Venture - Series Unknown 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cellcolabs
|
Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications. | $8.7M / Venture - Series Unknown / Mar 05, 2024 | |
Single Technologies
|
SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq. | $5.3M / Series A / Dec 03, 2020 | |
|
Single Technologies
|
SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq. | $7.7M / Seed / Nov 11, 2020 | |
Barnebys
|
Barnebys is the world’s leading search service for art, antiques and collectibles. We were founded in Stockholm, Sweden in 2011 and have since then established our business globally with offices in New York, UK, France, Spain and Germany. Our clients include the world’s top tier of auctioneers, antique dealers, galleries as well as regional andlocal businesses. We are also offering an extensive free database of auction results and a top of the line valuation service. We are now looking to grow our business even further and are seeking top talent to join our team. | Nov 15, 2017 |
Co-Investors
Inbox
1 deal together
Industrifonden
1 deal together
Kichi Invest
1 deal together
Norrsken VC
1 deal together
About Dopamine
Dopamine Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jens von Bahr
CEO and Co-Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jens von Bahr invest in?
Jens von Bahr invests primarily in Health Care, Biotechnology and Art startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jens von Bahr?
Public channels for Jens von Bahr include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jens von Bahr last invest?
The most recent investment recorded for Jens von Bahr closed in Mar 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
